UNBELIEVABLE: Rmd - Caught on Camera

This Analyst Just Upgraded ResMed Stock. Here's Why.

ResMed stock rallies on a bullish RBC Capital research note. Here’s why analyst Craig Wong-Pan raised his price target on RMD shares today.

Barchart · Sep 15

ResMed Stock: Is RMD Underperforming the Healthcare Sector?

ResMed has lagged behind the healthcare sector, and analysts remain moderately optimistic about the stock’s outlook.

Barchart · Sep 14

ResMed Stock: Analyst Estimates & Ratings

Although ResMed has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart · Aug 25

Is ResMed Stock Underperforming the Nasdaq?

ResMed has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Mar 12

ResMed Stock Outlook: Is Wall Street Bullish or Bearish?

As ResMed has outpaced the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart · Feb 18

Ozempic-style drugs prove to be 'a tailwind' for Resmed

Resmed has beaten expectations with $2 billion in second-quarter revenue and says weight loss drugs are actually boosting sales, rather than hurting them.

AAP · Jan 30

What You Need to Know Ahead of ResMed's Earnings Release

ResMed will release its second-quarter earnings soon, and analysts anticipate a low double-digit bottom-line growth.

Barchart · Jan 5

Is ResMed Stock Underperforming the S&P 500?

Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Barchart · Dec 8, 2025

What to Expect From ResMed's Next Quarterly Earnings Report

ResMed is expected to release its fiscal first-quarter earnings soon, and analysts project a double-digit earnings growth.

Barchart · Oct 7, 2025

How Is ResMed's Stock Performance Compared to Other Healthcare Stocks?

ResMed has significantly outperformed other healthcare stocks over the past year, and analysts remain bullish on the stock’s prospects.

Barchart · Sep 15, 2025